BMED iShares Health Innovation Active ETF
BMED focuses on total return by investing in the broad health sciences group of industries from R&D to production and distribution of medical supplies in different fields, including dental, optical or pharmaceuticals. It also involves healthcare providers including health facilities and hospitals or those providing related administrative, management or financial support. The fund reaches into non-human health (e.g., survival of plants and animals) such as firms that increase crop yields, taste, nutritional content or improve pet health. BMED will include firms with varying market-cap with bias to small- and mid-caps that may include foreign non-USD-denominated securities. The fund may also hold REITs that own hospitals and IPOs. During temporary defensive periods, the fund may invest up to 100% of assets in liquid, short-term investments and can enter in credit default swaps for risk management. Prior to Oct. 10, 2024, the fund used Blackrock for branding purposes instead of iShares.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| BMED | +7.5% | +12.6% | +20.2% | +25.4% | +19.4% | +4.5% |
| Equity average (4623 funds) | -2.1% | +2.7% | +87.6% | +61220.1% | +13.9% | +2.3% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: −$323K net.
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | MRNA MODERNA | 5.85% |
| 2 | GILD GILEAD SCIENCES | 5.78% |
| 3 | DHR DANAHER | 5.15% |
| 4 | ABBV ABBVIE | 4.85% |
| 5 | BMED BLK CSH FND TREASURY SL AGENCY | 4.60% |
| 6 | TMO THERMO FISHER SCIENTIFIC | 4.38% |
| 7 | EW EDWARDS LIFESCIENCES | 4.18% |
| 8 | BIIB BIOGEN | 3.69% |
| 9 | MTD METTLER TOLEDO | 3.60% |
| 10 | IQV IQVIA HOLDINGS INC | 3.57% |
| 11 | VRTX VERTEX PHARMACEUTICALS | 3.27% |
| 12 | MRK MERCK & CO INC | 2.93% |
| 13 | ROP.SW ROCHE PS PAR AG | 2.79% |
| 14 | GMAB GENMAB SPONSORED ADR | 2.64% |
| 15 | AMGN AMGEN INC | 2.54% |
| 16 | A AGILENT TECHNOLOGIES INC | 2.36% |
| 17 | NBIX NEUROCRINE BIOSCIENCES | 2.35% |
| 18 | WAT WATERS CORP | 2.26% |
| 19 | DXCM DEXCOM INC | 2.11% |
| 20 | ARGX ARGENX SE ADR | 1.83% |
| 21 | HALO HALOZYME THERAPEUTICS | 1.74% |
| 22 | CRL CHARLES RIVER LABORATORIES INTERNA | 1.60% |
| 23 | PFE PFIZER | 1.47% |
| 24 | ROIV ROIVANT SCIENCES LTD | 1.46% |
| 25 | TEVA TEVA PHARMACEUTICAL INDUSTRIES | 1.44% |
| 26 | ILMN ILLUMINA INC | 1.43% |
| 27 | GALD.SW GALDERMA GROUP N AG | 1.42% |
| 28 | BMY BRISTOL MYERS SQUIBB | 1.30% |
| 29 | ABT ABBOTT LABORATORIES | 1.29% |
| 30 | NOVN.SW NOVARTIS AG | 1.26% |
| 31 | JNJ JOHNSON & JOHNSON | 1.23% |
| 32 | MRK.DE MERCK | 1.22% |
| 33 | 2269.HK WUXI BIOLOGICS CAYMAN | 1.22% |
| 34 | GH GUARDANT HEALTH | 1.22% |
| 35 | CYTK CYTOKINETICS | 1.14% |
| 36 | BMRN BIOMARIN PHARMACEUTICAL | 1.00% |
| 37 | TEM TEMPUS AI CLASS A | 0.94% |
| 38 | UCB.BR UCB SA | 0.81% |
| 39 | PTGX PROTAGONIST THERAPEUTICS | 0.79% |
| 40 | AXSM AXSOME THERAPEUTICS | 0.73% |
| 41 | BRKR BRUKER | 0.70% |
| 42 | VRDN VIRIDIAN THERAPEUTICS ORS | 0.65% |
| 43 | ALKS ALKERMES | 0.62% |
| 44 | DNTH DIANTHUS THERAPEUTICS | 0.54% |
| 45 | RVMD REVOLUTION MEDICINES | 0.51% |
| 46 | PTCT PTC THERAPEUTICS | 0.44% |
| 47 | MBX MBX BIOSCIENCES | 0.43% |
| 48 | COGT COGENT BIOSCIENCES | 0.36% |
| 49 | SGMT SAGIMET BIOSCIENCES SERIES A | 0.14% |
| 50 | SMMT SUMMIT THERAPEUTICS | 0.08% |
| 51 | EIKN EIKON THERAPEUTICS | 0.06% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Jun 15, 2026 | $0.0812 |
| Dec 20, 2023 | $0.0072 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in BMED in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error